Taiwan · Delayed Price · Currency is TWD Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 18.44 billion. The enterprise value is 16.13 billion.
| Market Cap | 18.44B |
| Enterprise Value | 16.13B |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Jun 23, 2025 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 148.14M |
| Shares Outstanding | 148.14M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 12.55% |
| Owned by Institutions (%) | 23.16% |
| Float | 114.60M |
Valuation Ratios
The trailing PE ratio is 13.86.
| PE Ratio | 13.86 |
| Forward PE | n/a |
| PS Ratio | 1.70 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | 9.33 |
| P/OCF Ratio | 7.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.55, with an EV/FCF ratio of 8.16.
| EV / Earnings | 12.04 |
| EV / Sales | 1.48 |
| EV / EBITDA | 5.55 |
| EV / EBIT | 6.75 |
| EV / FCF | 8.16 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.47 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.13 |
| Interest Coverage | 640.35 |
Financial Efficiency
Return on equity (ROE) is 18.53% and return on invested capital (ROIC) is 13.19%.
| Return on Equity (ROE) | 18.53% |
| Return on Assets (ROA) | 9.88% |
| Return on Invested Capital (ROIC) | 13.19% |
| Return on Capital Employed (ROCE) | 20.75% |
| Revenue Per Employee | 21.71M |
| Profits Per Employee | 2.67M |
| Employee Count | 501 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.99 |
Taxes
In the past 12 months, Grape King Bio has paid 476.73 million in taxes.
| Income Tax | 476.73M |
| Effective Tax Rate | 18.95% |
Stock Price Statistics
The stock price has decreased by -17.82% in the last 52 weeks. The beta is 0.48, so Grape King Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -17.82% |
| 50-Day Moving Average | 127.71 |
| 200-Day Moving Average | 135.06 |
| Relative Strength Index (RSI) | 41.39 |
| Average Volume (20 Days) | 159,450 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 10.88 billion and earned 1.34 billion in profits. Earnings per share was 8.98.
| Revenue | 10.88B |
| Gross Profit | 8.35B |
| Operating Income | 2.37B |
| Pretax Income | 2.52B |
| Net Income | 1.34B |
| EBITDA | 2.82B |
| EBIT | 2.37B |
| Earnings Per Share (EPS) | 8.98 |
Balance Sheet
The company has 3.88 billion in cash and 247.29 million in debt, giving a net cash position of 3.63 billion or 24.52 per share.
| Cash & Cash Equivalents | 3.88B |
| Total Debt | 247.29M |
| Net Cash | 3.63B |
| Net Cash Per Share | 24.52 |
| Equity (Book Value) | 11.12B |
| Book Value Per Share | 66.19 |
| Working Capital | 1.65B |
Cash Flow
In the last 12 months, operating cash flow was 2.52 billion and capital expenditures -541.03 million, giving a free cash flow of 1.98 billion.
| Operating Cash Flow | 2.52B |
| Capital Expenditures | -541.03M |
| Free Cash Flow | 1.98B |
| FCF Per Share | 13.34 |
Margins
Gross margin is 76.77%, with operating and profit margins of 21.76% and 12.32%.
| Gross Margin | 76.77% |
| Operating Margin | 21.76% |
| Pretax Margin | 23.13% |
| Profit Margin | 12.32% |
| EBITDA Margin | 25.92% |
| EBIT Margin | 21.76% |
| FCF Margin | 18.18% |
Dividends & Yields
This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 5.54%.
| Dividend Per Share | 6.90 |
| Dividend Yield | 5.54% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 106.12% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 5.53% |
| Earnings Yield | 7.27% |
| FCF Yield | 10.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
| Last Split Date | Sep 15, 2005 |
| Split Type | Forward |
| Split Ratio | 1.0205 |
Scores
Grape King Bio has an Altman Z-Score of 5.31 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.31 |
| Piotroski F-Score | 6 |